Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 2Phase 1 2Phase 3 1

Status

Completed 4Terminated 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Neoplasms 2Zollinger-Ellison Syndrome 1Vomiting 1Prostatic Neoplasms 1Pancreatitis 1Pancreatic Neoplasms 1Ototoxicity 1Osteosarcoma 1Neoplasm Metastasis 1Gastrinoma 1Duodenal Neoplasms 1Breast Neoplasms 1

Interventions

Cisplatin 1519Carboplatin 1420Cyclophosphamide 1360Gemcitabine 1235Bevacizumab 1226Paclitaxel 1211Radiotherapy 1176Docetaxel 1080pembrolizumab 1028Oxaliplatin 936Capecitabine 901Fluorouracil 833Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 666Etoposide 660Irinotecan 622Leucovorin 575Pemetrexed 510Drug Therapy 493Cetuximab 483Trastuzumab 469Cytarabine 466Magnetic Resonance Spectroscopy 458Filgrastim 446Prednisone 433Lenalidomide 409Specimen Handling 408Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Interventional × Pantoprazole × Clear all
NCT05251233 2025-05-06

Role of Proton Pump Inhibitors on the Postoperative Course Following Pancreaticoduodenectomy

Washington University School of Medicine

Phase 2 Terminated
56 enrolled 11 charts
Gastrointestinal

Duodenal Neoplasms, Pancreatic Neoplasms, Pancreatitis

NCT03948477 2022-05-25

PantoCIN

University of Auckland, New Zealand

Phase 2 Completed
160 enrolled
Breast

Breast Neoplasms, Neoplasms, Vomiting

NCT01748500 2021-03-23

Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate Cancer

University Health Network, Toronto

Phase 2 Completed
21 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT01848457 2020-03-16

Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy

Children's Hospital of Philadelphia

Phase 2 Completed
13 enrolled 15 charts
Sarcoma

Ototoxicity, Neoplasms, Osteosarcoma

NCT00001191 2017-07-02

The Use of Oral Omeprazole and Intravenous Pantoprazole in Patients With Hypersecretion of Gastric Acid

National Institutes of Health Clinical Center (CC)

Phase 2 Completed

Zollinger-Ellison Syndrome, Gastrinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡